Summary
Diabetes mellitus is an independent risk factor in the development of atherosclerosis. In this study we aimed to demonstrate whether there is an abnormal interaction between low-density lipoproteins from diabetic patients and human macrophages. We measured cholesteryl ester synthesis and cholesteryl ester accumulation in human monocytederived macrophages (obtained from non-diabetic donors) incubated with low density lipoproteins from Type 1 (insulin-dependent) diabetic patients in good or fair glycaemic control. Low density lipoproteins from the diabetic patients stimulated more cholesteryl ester synthesis than low density lipoproteins from non-diabetic control subjects (7.19±1.19 vs 6.11±0.94 nmol/mg cell protein/20 h, mean±SEM, p<0.05). The stimulation of cholesteryl ester synthesis by low density lipoproteins isolated from diabetic patients was paralleled by a significant increase in intracellular cholesteryl ester accumulation (p<0.02). There were no significant differences in the lipid composition of low density lipoproteins between the diabetic and control groups. Non-enzymatic glycosylation of low density lipoproteins was higher in the diabetic group (p<0.01) and correlated significantly with cholesteryl ester synthesis (r=0.58). Similarly, low-density lipoproteins obtained from non-diabetic subjects and glycosylated in vitro stimulated more cholesteryl ester synthesis in macrophages than control low density lipoproteins. The increase in cholesteryl ester synthesis and accumulation by cells exposed to low density lipoproteins from diabetic patients seems to be mediated by an increased uptake of these lipoproteins by macrophages. This study suggests that glycosylation of low density lipoproteins to the extent occurring in diabetes may alter their interaction with human monocyte-derived macrophages and may lead to increased intracellular cholesteryl ester accumulation. The results suggest a possible mechanism by which hyperglycaemia may contribute to the acceleration of atherosclerosis in diabetes.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
West KM (1982) Hyperglycaemia as a cause of long-term complications. In: Keen H, Jarrett RJ (eds) Complications of diabetes. Edward Arnold, London, pp 13–18
Nomenclature Committee of IUB, Joint Commission on Biochemical Nomenclature, Newsletter (1984) Biochem J 217: I-IV
Gottshalk A (1972) Interaction between reducing sugars and amino-acids under neutral and acidic conditions. In: Gottshalk A (ed) Glycoproteins. Elsevier, Amsterdam, pp 141–157
Kennedy L, Baynes JW (1984) Nonenzymatic glycosylation and the chronic complications of diabetes: an overview. Diabetologa 26: 93–98
Monnier VM, Cerami A (1981) Non-enzymatic browning in vivo. Possible process for aging of long-lived proteins. Science 211: 491–493
Monnier VM, Stevens VJ, Cerami A (1979) Non-enzymatic glycosylation, sulfhydryl oxidation and aggregation of lens protein in experimental sugar cataracts. J Exp Med 150: 1098–1107
Yue DK, McLennan S, Delbridge L, Handelsman DJ, Reeve T, Turtle JR (1983) The thermal stability of collagen in diabetic rats: correlation with severity of diabetes and nonenzymatic glycosylation. Diabetologia 24: 282–285
Kent MJC, Light ND, Bailey AJ (1985) Evidence for glucose-mediated covalent cross-linking of collagen after glycosylation in vitro. Biochem J 225: 745–752
Gonen B, Baenziger J, Schonfeld G, Jacobson D, Farrar P (1981) Nonenzymatic glycosylation of low density lipoproteins in vitro. Diabetes 30: 875–878
Witztum JL, Mahoney EM, Branks MJ, Fisher M, Elam R, Steinberg D (1982) Nonenzymatic glucosylation of low density lipoprotein alters its biologic activity. Diabetes 31: 283–291
Kannel WB, McGee DL (1979) Diabetes and cardiovascular disease. The Framingham Study. JAMA 241: 2035–2038
Curtiss LK, Witztum JL (1985) Plasma apolipoproteins AI, AII, B, CI and E are glucosylated in hyperglycemie diabetic subjects. Diabetes 34: 452–461
Sasaki J, Cottam GL (1982) Glycosylation of LDL decreases its ability to interact with high affinity receptors of human fibroblasts in vitro and decreases its clearance from rabbit plasma in vivo. Biochim Biophys Acta 713: 199–207
Steinbrecher UP, Witztum JL (1984) Glucosylation of low density lipoproteins to an extent comparable to that seen in diabetes slows their catabolism. Diabetes 33: 130–134
Lopes-Virella MF, Sherer GK, Lees AM, Wohltmann H, Mayfield R, Sagel J, LeRoy EC, Colwell JA (1982) Surface binding, internalisation and degradation by cultured human fibroblasts of low density lipoproteins isolated from Type 1 (insulin-dependent) diabetic patients: changes with metabolic control. Diabetologia 22: 430–436
Kraemer FB, Chen Y-DI, Cheung RMC, Reaven GM (1982) Are the binding and degradation of low density lipoprotein altered in Type 2 (non-insulin-dependent) diabetes mellitus? Diabetologia 23: 28–33
Hiramatsu K, Bierman EL, Chait A (1985) Metabolism of low density lipoprotein from patients with diabetic hypertriglyceridemia by cultured human skin fibroblasts. Diabetes 34: 8–14
Ross R (1981) Atherosclerosis: a problem of the biology of the arterial wall cells and their interaction with blood components. Arteriosclerosis 1: 293–311
Pitas RE, Innerarity TL, Mahley RB (1981) Foam cells in explants of atherosclerotic rabbit aortas have receptors for β-very low density lipoproteins and modified low density lipoproteins. Arteriosclerosis 3: 1–12
National Diabetes Data Group (1979) Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance. Diabetes 28: 1039–1057
Stevenson HC, Beman JA, Oldham RK (1983) Design of a cancer immunology cytapheresis unit. Plasma Ther 4: 57–63
Stevenson HC (1985) Separation of mononuclear leukocyte subsets by counter current centrifugation elutriation. In: Gisabato G, Langone T, von Vunakis H (eds) Methods in enzymology: immunochemical techniques, Part G. Academic, New York, pp 242–249
Stevenson HC, Katz P, Wright DG, Contreras TJ, Jemionek JF, Hartwig VM, Flor WJ, Fauci AS (1981) Human blood monocytes: characterization of the negatively selected human monocyte and their suspension cell culture derivatives. Scand J Immunol 14: 243–256
Stevenson HC, Miller P, Akiyama Y, Favilla T, Beman JA, Herberman R, Stull H, Thurman G, Maluish A, Oldham R (1983) A system for obtaining large numbers of cryopreserved human monocytes purified by leukapheresis and counter-current centrifugation elutriation. J Immunol Methods 62: 353–363
Havel RJ, Eder HA, Bragdon JH (1955) The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum. J Clin Invest 34: 1345–1353
Goldstein JL, Dana SE, Brown MS (1974) Esterification of low density lipoprotein cholesterol in human fibroblasts and its absence in homozygous familial hypercholesterolemia. Proc Natl Acad Sci USA 71: 4288–4292
Folch J, Lees M, Stanley GHS (1957) A simple method for the isolation and purification of total lipids from animal tissues. J Biol Chem 226: 497–509
Lowry OH, Rosebrough NJ, Farr AL, Randall BJ (1951) Protein measurement with the Folin phenol reagent. J Biol Chem 193: 265–275
Chait A, Eisenberg S, Steinmetz A, Albers JJ, Bierman EL (1984) Low density lipoproteins modified by lipid transfer protein have altered biological activity. Biochim Biophys Acta 795: 314–325
Goldstein JL, Brown MS (1977) The low-density lipoprotein pathway and its relation to atherosclerosis. Ann Rev Biochem 46: 897–930
Ishikawa TT, McGee Y, Morrison JA, Glueck CJ (1974) Quantitative analyses of cholesterol in 5 to 20 μl of plasma. J Lipid Res 15: 286–291
Bierman EL, Stein O, Stein Y (1979) Lipoprotein uptake and metabolism by rat aortic smooth muscle cells in tissue culture. Circ Res 35: 136–150
Manual of Lipid Operations (1974) Lipid Research Clinics Program, Vol 1. Lipid and Lipoprotein Analysis. Department of Health, Education and Welfare, Publ No (NIH) 75-628
Bartlett GR (1959) Phosphorus assay in column chromatography. J Biol Chem 234: 466–468
Lyons TJ, Baynes JW, Patrick JS, Colwell JA, Lopes-Virella MF (1986) Glycosylation of LDL in patients with Type 1 (insulin-dependent) diabetes: correlations with other parameters of glycaemic control. Diabetologia 29: 685–689
Yue DK, McLennan S, Turtle JR (1981) Non-enzymatic glycosylation of tissue protein in diabetes in the rat. Diabetologia 24: 377–381
Kadish AH, Little RL, Steinberg JC (1986) A new and rapid method for the determination of glucose by measurement of rate of oxygen consumption. Clin Chem 14: 116–131
Spicer KN, Allen RC, Buse MG (1978) A simplified assay of hemoglobin A1c in diabetic patients, using isoelectric focusing and quantitative microdensitometry. Diabetes 27: 384–388
Lopes-Virella MF, Stone P, Ellis S, Colwell JA (1977) Cholesterol determination in high density lipoproteins separated by three different methods. Clin Chem 23: 882–884
Garcia MJ, McNamara PM, Gordon T, Kannell WB (1974) Morbidity and mortality in diabetics in the Framingham population. Diabetes 23: 105–111
Gordon T, Castelli WP, Hjortland MC, Kannel WB, Dawber TR (1977) Diabetes, blood lipids and the role of obesity in coronary heart disease risk for women. Ann Intern Med 87: 393–397
Lopes-Virella MF, Klein RL, Lyons TJ, Stevenson HC, Witztum JL (1988) Glycosylation of low density lipoprotein enhances cholesteryl ester synthesis in human monocyte-derived macrophages. Diabetes 37 (in press)
Higuchi Y (1982) Lipid peroxides and γ-tocopherol in rat streptozotocin-induced diabetes mellitus. Acta Med Okayama 36: 165–168
Niohigaki I, Hagihava M, Tsunekawa H, Maseki M, Yagi K (1981) Lipid peroxide levels in serum lipoprotein fractions of diabetic patients. Biochem Med 25: 273–278
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Lyons, T.J., Klein, R.L., Baynes, J.W. et al. Stimulation of cholesteryl ester synthesis in human monocyte-derived macrophages by low-density lipoproteins from Type 1 (insulin-dependent) diabetic patients: the influence of non-enzymatic glycosylation of low-density lipoproteins. Diabetologia 30, 916–923 (1987). https://doi.org/10.1007/BF00295874
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF00295874